Search the MBS

MRI—scan of wrist following radiographic examination for a patient under 16 years if a scaphoid fracture is suspected (R) (Contrast)

Bulk bill incentive

Fee: $502.25 Benefit: 75% = $376.70 85% = $426.95

• Previous - Item 63519
• Next - Item 63531

MRI—scan of both breasts, if:

(a) a dedicated breast coil is used; and
(b) the request for the scan identifies that:
(i) the patient has a breast lesion; and
(ii) the results of conventional imaging are inconclusive for the presence of breast cancer; and
(iii) biopsy has not been possible (R) (Contrast)

Bulk bill incentive

Fee: $773.65 Benefit: 75% = $580.25 85% = $669.15

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63522
• Next - Item 63533

MRI—scan of both breasts, if:

(a) a dedicated breast coil is used; and
(b) the request for the scan identifies that:
(i) the patient has been diagnosed with a breast cancer; and
(ii) there is a discrepancy between the clinical assessment and the conventional imaging assessment of the extent of the malignancy; and
(c) the results of breast MRI imaging may alter treatment planning (R) (Contrast)

Bulk bill incentive

Fee: $773.65 Benefit: 75% = $580.25 85% = $669.15

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63531
• Next - Item 63539

MRI—scan of the abdomen, requested by a specialist or consultant physician, to assess the development or growth of renal tumours in a patient with a confirmed clinical or molecular diagnosis of a genetic disorder associated with an increased risk of developing renal tumours, other than a service to which item 63540 applies

Applicable once in any 12 month period

(R) (Contrast)

Bulk bill incentive

Fee: $703.20 Benefit: 75% = $527.40 85% = $598.70

• Previous - Item 63533
• Next - Item 63540

MRI—scan of the abdomen, requested by a specialist or consultant physician, to assess a patient with one or more known renal tumours and with a confirmed clinical or molecular diagnosis of a genetic disorder associated with an increased risk of developing renal tumours, if the service is performed:

(a) to evaluate changes in clinical condition or suspected complications of the known renal tumours; or

(b) where a disease specific line of treatment has been initiated and an assessment of patient responsiveness to the treatment is required

Applicable once in any 3 month period

(R) (Contrast)

Bulk bill incentive

Fee: $703.20 Benefit: 75% = $527.40 85% = $598.70

• Previous - Item 63539
• Next - Item 63541

Multiparametric MRI—scan of the prostate for the detection of cancer, requested by a specialist in the speciality of urology, radiation oncology or medical oncology:

(a) if the request for the scan identifies that the patient is suspected of developing prostate cancer:

(i) on the basis of a digital rectal examination; or

(ii) in the circumstances mentioned in clause 2.5.9A; and

(b) using a standardised image acquisition protocol involving:

(i) T2‑weighted imaging; and

(ii) diffusion‑weighted imaging; and

(iii) (unless contraindicated) dynamic contrast enhancement 

(R) 

Note:  See explanatory note IN.5.1 for the meaning of Clause 2.5.9 in the descriptor for this item and the claiming limitations.

Bulk bill incentive

Fee: $504.45 Benefit: 75% = $378.35 85% = $428.80

(See para IN.0.19, IN.5.1 of explanatory notes to this Category)

• Previous - Item 63540
• Next - Item 63543

Multiparametric MRI—scan of the prostate for the assessment of cancer, requested by a specialist in the speciality of urology, radiation oncology or medical oncology:

(a) if the request for the scan identifies that the patient:

(i) is under active surveillance following a confirmed diagnosis of prostate cancer by biopsy histopathology; and

(ii) is not undergoing, or planning to undergo, treatment for prostate cancer; and

(b) using a standardised image acquisition protocol involving:

(i) T2‑weighted imaging; and

(ii) diffusion‑weighted imaging; and

(iii) (unless contraindicated) dynamic contrast enhancement

(R)

Note: See explanatory note IN.5.2 for claiming restrictions for this item.

Bulk bill incentive

Fee: $504.45 Benefit: 75% = $378.35 85% = $428.80

(See para IN.0.19, IN.5.2 of explanatory notes to this Category)

• Previous - Item 63541
• Next - Item 63545

MRI - multiphase scans of liver (including delayed imaging, if performed) with a contrast agent, for characterisation, or staging where surgical resection or interventional techniques are under consideration, if:

(a) the patient has a confirmed extra‑hepatic primary malignancy (other than hepatocellular carcinoma); and

(b) computed tomography is negative or inconclusive for hepatic metastatic disease; and

(c) the identification of liver metastases would change the patient’s treatment planning

Applicable not more than once in a 12 month period (R) (Contrast)

Bulk bill incentive

Fee: $616.60 Benefit: 75% = $462.45 85% = $524.15

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63543
• Next - Item 63546

MRI – multiphase scans of the liver (including delayed imaging, if performed) with a contrast agent, for diagnosis or staging, if:

(a) the patient has:
(i) known or suspected hepatocellular carcinoma; and
(ii) chronic liver disease that has been confirmed by a specialist or consultant physician; and
(b) the patient’s liver function has been identified as Child Pugh class A or B; and
(c) the patient has an identified hepatic lesion over 10 mm in diameter.
For any particular patient—applicable not more than once in a 12 month period (R) (Contrast)

Bulk bill incentive

Fee: $616.60 Benefit: 75% = $462.45 85% = $524.15

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63545
• Next - Item 63547

MRI—scan of both breasts for the detection of cancer, if:

(a) a dedicated breast coil is used; and
(b) the request for the scan identifies that:
(i) the patient has a breast implant in situ; and
(ii) anaplastic large cell lymphoma has been diagnosed
(R) (Contrast)

Bulk bill incentive

Fee: $773.65 Benefit: 75% = $580.25 85% = $669.15

(See para IN.0.19 of explanatory notes to this Category)

• Previous - Item 63546
• Next - Item 63549